There is great news for people struggling with Corona in India. The world’s largest manufacturer of vaccines has said that it is working on giving vaccine in India first. Its goal is on how we give vaccine in India first. Let me tell you that this company belongs to India only. The world’s highest vaccine is produced here.
Adar Poonawalla answer Who will get first dose of vaccine
Adar Poonawalla, the chief executive of Serum Institute of India – SII, has said that the focus of his company is to give AstraZeneca vaccine first in India. After that supply to other countries of the world. Serum Institute AstraZeneca is producing the pharmaceutical company’s vaccine in India.
Adar Poonawala said that our biggest responsibility is to worry about our country first. After that we go to the Covax facility, then talk about other agreements and deals. That’s why India and people of India are first on my priority list. The Kovac facility is being decided to provide a vaccine for poor countries of the world.
AstraZeneca drug company claimed that the drug company was 90 percent effective
the Government of India to buy the vaccine. SII will have so much vaccine by the first quarter of 2021 that it can sell the vaccine in Indian markets. Adar Poonawalla’s statement came shortly after the statement of the AstraZeneca drug company claimed that the drug company was 90 percent effective in stopping Corona.
AstraZeneca has also claimed that their vaccine is the cheapest, safe and efficient vaccine in the world. The company said that they have a complete policy for its cheap production and smooth distribution. Now the Serum Institute and AstraZeneca will petition the government at the end of the year to allow them to make emergency use of their vaccine.
Vaccine will come in the market by February-March 2021
If Adar Poonawala believes, his vaccine will come in the market by February-March next year. He told that the cost of one dodge of his vaccine will be around one thousand rupees. If the government asks for supply on a large scale, then the price can also be reduced. This will decide how many medicines the company gets orders for supply.
Poonawalla said that SII has the right to directly enter into agreements with more than five dozen countries on vaccines. It can do this under an agreement with AstraZeneca. Adar claims that SII can supply 40 million doses of the AstraZeneca vaccine from its Indian unit by July 2021.